Neuro-Oncology Reviews

Volume 25 Number 2
31 January 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 2, 31 January

Scherm A, Ippen FM, Hau P, Baurecht H, Wick W, Gempt J, Knüttel H, Leitzmann MF, Seliger C.
Targeted therapies in patients with newly diagnosed glioblastoma-A systematic meta-analysis of randomized clinical trials.
Int J Cancer. 2023 Jan 16
. doi: 10.1002/ijc.34433. PMID: 36647335. Review, Meta-analysis. ˍ

Vallero SG, Bertero L, Morana G, Sciortino P, Bertin D, Mussano A, Ricci FS, Peretta P, Fagioli F.
Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type.
Front Oncol. 2023 Jan 16, 2022;12:1082062
. doi: 10.3389/fonc.2022.1082062. PMID: 36727064. Review. ˍ

Arrieta VA, Dmello C, McGrail DJ, Brat DJ, Lee-Chang C, Heimberger AB, Chand D, Stupp R, Sonabend AM.
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment.
J Clin Invest. 2023 Jan 17;133(2):e163447
. doi: 10.1172/JCI163447. PMID: 36647828. Review. ˍ

Gonzalez Castro LN, Arrillaga-Romany IC, Batchelor TT.
Challenges and Opportunities for Clinical Trials in Patients With Glioma.
JAMA Neurol. 2023 Jan 17
. doi: 10.1001/jamaneurol.2022.4924. PMID: 36648934. Viewpoint˰ ˍ

Johanssen T, McVeigh L, Erridge S, Higgins G, Straehla J, Frame M, Aittokallio T, Carragher NO, Ebner D.
Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia.
Front Oncol. 2023 Jan 17, 2022;12:1075559
. doi: 10.3389/fonc.2022.1075559. PMID: 36733367. Review. ˍ

Najafi M, Jahanbakhshi A, Finocchi Ghersi S, Giaccherini L, Botti A, Cavallieri F, Rossi J, Iori F, Iotti C, Ciammella P, Nabiuni M, Gomar M, Rezaie O, Cozzi S.
Clinical Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A Systematic Review.
Brain Sci. 2023 Jan 17;13(2):159
. doi: 10.3390/brainsci13020159. PMID: 36831702. Review. ˍ

Thirugnanasambandam RP, Silva GMV, Wu AH, Kim CJ, Cimpeanu E, Minkowitz J, Shao CY, Chiu E.
Cystic Glioblastoma: A Mimicker of Infection? A Case Report and Literature Review.
Case Rep Oncol Med. 2023 Jan 17;2023:7348188
. doi: 10.1155/2023/7348188. PMID: 36704640. Case report, Review. ˍ

Soni N, Ora M, Jena A, Rana P, Mangla R, Ellika S, Almast J, Puri S, Meyers SP.
Amino Acid Tracer PET MRI in Glioma Management: What a Neuroradiologist Needs to Know.
AJNR Am J Neuroradiol. 2023 Jan 19
. doi: 10.3174/ajnr.A7762. PMID: 36657945. Review. ˍ

Chen Y, Zhao C, Li S, Wang J, Zhang H.
Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma.
Cancers (Basel). 2023 Jan 18;15(3):602
. doi: 10.3390/cancers15030602. PMID: 36765560. Review. ˍ

Kalluri AL, Shah PP, Lim M.
The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches.
Int J Mol Sci. 2023 Jan 19;24(3):2020
. doi: 10.3390/ijms24032020. PMID: 36768342. Review. ˍ


Kao YS, Yeh CC, Chen YF.
The Relationship between Cancer and Dementia: An Updated Review.
Cancers (Basel). 2023 Jan 19;15(3):640
. doi: 10.3390/cancers15030640. PMID: 36765598. Review. ˍ

Romano A, Palizzi S, Romano A, Moltoni G, Di Napoli A, Maccioni F, Bozzao A.
Diffusion Weighted Imaging in Neuro-Oncology: Diagnosis, Post-Treatment Changes, and Advanced Sequences-An Updated Review.
Cancers (Basel). 2023 Jan 19;15(3):618
. doi: 10.3390/cancers15030618. PMID: 36765575. Review. ˍ

Vymazal J, Kazda T, Novak T, Slanina P, Sroubek J, Klener J, Hrbac T, Syrucek M, Rulseh AM.
Eighteen years' experience with tumor treating fields in the treatment of newly diagnosed glioblastoma.
Front Oncol. 2023 Jan 19;12:1014455
. doi: 10.3389/fonc.2022.1014455. PMID: 36741707. Observational study, Review. ˍ

Collée E, Vincent A, Visch-Brink E, De Witte E, Dirven C, Satoer D.
Localization patterns of speech and language errors during awake brain surgery: a systematic review.
Neurosurg Rev. 2023 Jan 20;46(1):38
. doi: 10.1007/s10143-022-01943-9. PMID: 36662312. Review. ˍ

McLaughlin A, Lakshmanan R, Dyke J, Warne R, Saha S, Lind C, Bynevelt M.
Diffuse paediatric cerebellar glioma: two identical imaging phenotypes of an extremely rare entity with disparate pathology.
Childs Nerv Syst. 2023 Jan 20
. doi: 10.1007/s00381-023-05836-0. PMID: 36658366. Case report, Review˰ ˍ

Morimoto T, Nakazawa T, Maeoka R, Nakagawa I, Tsujimura T, Matsuda R.
Natural Killer Cell-Based Immunotherapy against Glioblastoma.
Int J Mol Sci. 2023 Jan 20;24(3):2111
. doi: 10.3390/ijms24032111. PMID: 36768432. Review. ˍ

Ritchey AK et al, PDQ Pediatric Treatment Editorial Board.
Childhood Brain Stem Glioma Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2023 Jan 20. Bookshelf ID: NBK65856. PMID: 26389295. Review. ˍ

Salari N, Ghasemi H, Fatahian R, Mansouri K, Dokaneheifard S, Shiri MH, Hemmati M, Mohammadi M.
The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis.
Eur J Med Res. 2023 Jan 20;28(1):39
. doi: 10.1186/s40001-023-01011-y. PMID: 36670466. Review, Meta-analysis. ˍ

Dighe OR, Korde P, Bisen YT, Iratwar S, Kesharwani A, Vardhan S, Singh A.
Emerging Recombinant Oncolytic Poliovirus Therapies Against Malignant Glioma: A Review.
Cureus. 2023 Jan 21;15(1):e34028
. doi: 10.7759/cureus.34028. PMID: 36814733. Review. ˍ

Anastasaki C, Gao Y, Gutmann DH.
Neurons as stromal drivers of nervous system cancer formation and progression.
Dev Cell. 2023 Jan 23;58(2):81-93. doi: 10.1016/j.devcel.2022.12.011
. PMID: 36693322. Review. ˍ

Vacher E, Rodriguez Ruiz M, Rees JH.
Management of brain tumour related epilepsy (BTRE): a narrative review and therapy recommendations.
Br J Neurosurg. 2023 Jan 24:1-8
. doi: 10.1080/02688697.2023.2170326. PMID: 36694327. Review˰ ˍ

Pineda E, Domenech M, Hernández A, Comas S, Balaña C.
Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects.
Onco Targets Ther. 2023 Jan 25;16:71-86
. doi: 10.2147/OTT.S366371. PMID: 36721854. Review. ˍ

Thrull M, Atasi K, Boese LM, Cakar M, Heller U, Jansen N, Menzel LC, Omaimen H, Theis K, Karacic D, Dimov D, Coras R, Klingebiel R.
Transdural Skull Base Infiltration by Glioblastoma: Case Report and Review of the Literature.
Case Rep Otolaryngol. 2023 Jan 25;2023:4727288
. doi: 10.1155/2023/4727288. PMID: 36742066. Case report, Review. ˍ

Wang F, Dong J, Zhang J, Zhao H, Wang N, Jin J, Yan X, Gao X, Liu H, Hu S.
Rapid progression of subcutaneous glioblastoma: A case report and literature review.
Front Oncol. 2023 Jan 25;13:935944
. doi: 10.3389/fonc.2023.935944. PMID: 36761958. Case report, Review. ˍ

Greuter L, Hallenberger T, Guzman R, Soleman J.
Neurosurgical Treatment and Outcome of Pediatric Skull Base Lesions: A Case Series and Review of the Literature.
Children (Basel). 2023 Jan 26;10(2):216
. doi: 10.3390/children10020216. PMID: 36832345. Case report, Review. ˍ

Jiang S, Chai H, Tang Q.
Advances in the intraoperative delineation of malignant glioma margin.
Front Oncol. 2023 Jan 26;13:1114450
. doi: 10.3389/fonc.2023.1114450. PMID: 36776293. Review. ˍ


Ma Y, Wang Y, Nie C, Lin Y.
The efficacy of targeted therapy combined with radiotherapy and temozolomide-based chemotherapy in the treatment of glioma: A systemic review and meta-analysis of phase II/III randomized controlled trials.
Front Oncol. 2023 Jan 26;13:1082539
. doi: 10.3389/fonc.2023.1082539. PMID: 36776303. Review, Meta-analysis. ˍ

Martucci M, Russo R, Schimperna F, D'Apolito G, Panfili M, Grimaldi A, Perna A, Ferranti AM, Varcasia G, Giordano C, Gaudino S.
Magnetic Resonance Imaging of Primary Adult Brain Tumors: State of the Art and Future Perspectives.
Biomedicines. 2023 Jan 26;11(2):364
. doi: 10.3390/biomedicines11020364. PMID: 36830900. Review. ˍ

Xie X, Bao S, Zhao H, Li L, Fu X.
Efficacy and safety of bevacizumab for treating glioblastoma: a systematic review and meta-analysis of phase II and III randomized controlled trials.
Cancer Invest. 2023 Jan 27:1-15
. doi: 10.1080/07357907.2023.2174261. PMID: 36705341. Review, Meta-analysis˰ ˍ

Elias AF, Lin BC, Piggott BJ.
Ion Channels in Gliomas-From Molecular Basis to Treatment.
Int J Mol Sci. 2023 Jan 28;24(3):2530
. doi: 10.3390/ijms24032530. PMID: 36768856. Review. ˍ

Zhang AB, Mozaffari K, Aguirre B, Li V, Kubba R, Desai NC, Wei D, Yang I, Wadehra M.
Exploring the Past, Present, and Future of Anti-Angiogenic Therapy in Glioblastoma.
Cancers (Basel). 2023 Jan 29;15(3):830
. doi: 10.3390/cancers15030830. PMID: 36765787. Review. ˍ

Choi JY.
Medulloblastoma: Current Perspectives and Recent Advances.
Brain Tumor Res Treat. 2023 Jan 30;11(1):28-38
. doi: 10.14791/btrt.2022.0046. PMID: 36762806. Review. ˍ

Gkantinas G, Tataki EΙ, Lykoudis PM, Lelekaki E, Kouki P.
Clinical Effects and Adverse Events Associated With Desflurane Use in Adult Patients Undergoing Supratentorial Craniotomy: A Systematic Review.
J Neurosurg Anesthesiol. 2023 Jan 30
. doi: 10.1097/ANA.0000000000000905. PMID: 36706431. Review˰ ˍ

Lim DH.
Role of Radiotherapy in Patients With Relapsed Medulloblastoma.
Brain Tumor Res Treat. 2023 Jan 30;11(1):22-27
. doi: 10.14791/btrt.2022.0033. PMID: 36762805. Review. ˍ

Parsels LA, Wahl DR, Koschmann C, Morgan MA, Zhang Q.
Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma.
Neoplasia. 2023 Jan 30;37:100881
. doi: 10.1016/j.neo.2023.100881. PMID: 36724689. Review. ˍ

Rahman R, Janowski M, Killick-Cole CL, Singleton WGB, Campbell E, Walczak P, Khatua S, Faltings L, Symons M, Schneider JR, Kwan K, Boockvar JA, Gill SS, Oliveira JM, Beccaria K, Carpentier A, Canney M, Pearl M, Veal GJ, Meijer L, Walker DA.
Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials.
Cancers (Basel). 2023 Jan 30;15(3):857
. doi: 10.3390/cancers15030857. PMID: 36765816. Review. ˍ

Reuss DE.
Updates on the WHO diagnosis of IDH-mutant glioma.
J Neurooncol. 2023 Jan 30
. doi: 10.1007/s11060-023-04250-5. PMID: 36717507. Review. ˍ

Rivera D, Schupper AJ, Bouras A, Anastasiadou M, Kleinberg L, Kraitchman DL, Attaluri A, Ivkov R, Hadjipanayis CG.
Neurosurgical Applications of Magnetic Hyperthermia Therapy.
Neurosurg Clin N Am. 2023 Jan 30;34(2):269-283. doi: 10.1016/ PMID: 36906333. Review˰ ˍ

Gatto L, Franceschi E, Tosoni A, Di Nunno V, Bartolini S, Brandes AA.
Glioblastoma treatment slowly moves towards change: novel druggable targets and translational horizons in 2022.
Expert Opin Drug Discov. 2023 Jan 31
. doi: 10.1080/17460441.2023.2174097. PMID: 36718723. Review˰ ˍ

Huang Z, Dewanjee S, Chakraborty P, Jha NK, Dey A, Gangopadhyay M, Chen XY, Wang J, Jha SK.
CAR T cells: engineered immune cells to treat brain cancers and beyond.
Mol Cancer. 2023 Jan 31;22(1):22
. doi: 10.1186/s12943-022-01712-8. PMID: 36721153. Review. ˍ

Szasz AM, Arrojo Alvarez EE, Fiorentini G, Herold M, Herold Z, Sarti D, Dank M.
Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas.
Cancers (Basel). 2023 Jan 31;15(3):880
. doi: 10.3390/cancers15030880. PMID: 36765840. Meta-analysis. ˍ